(Q37624712)

21 August 2017

1 reference

title

Invasive fungal infections: the challenge continues (English)

1 reference

invasive fungal infections

21 August 2017

main subject

1 reference

Antonino Gullo

1

1 reference

21 August 2017

publication date

1 January 2009

1 reference

21 August 2017

1 reference

21 August 2017

volume

69 Suppl 1

1 reference

21 August 2017

page(s)

65-73

1 reference

https://scigraph.springernature.com/pub.10.2165/11315530-000000000-00000

21 August 2017

exact match

0 references

cites work

Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F11315530-000000000-00000

Duration of antifungal treatment and development of delayed complications in patients with candidaemia

21 January 2018

1 reference

12 December 2020

Combination antifungal therapy: what can and should we expect?

1 reference

12 December 2020

Efficacy of caspofungin in invasive candidiasis and candidemia--de-escalation strategy

1 reference

12 December 2020

Phase 2, randomized, dose-ranging study evaluating the safety and efficacy of anidulafungin in invasive candidiasis and candidemia

1 reference

12 December 2020

Current challenges in the management of invasive fungal infections

1 reference

12 December 2020

The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee

1 reference

12 December 2020

1 reference

12 December 2020

Secondary prophylaxis of invasive fungal infections with combination antifungal therapy and G-CSF-mobilized granulocyte transfusions in three children with hematological malignancies

1 reference

12 December 2020

In vitro susceptibility of invasive isolates of Candida spp. to anidulafungin, caspofungin, and micafungin: six years of global surveillance.

1 reference

12 December 2020

Usefulness of biological markers in the diagnosis of invasive candidiasis

1 reference

12 December 2020

The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy

1 reference

12 December 2020

Hospital-acquired candidemia. The attributable mortality and excess length of stay

1 reference

12 December 2020

The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer

1 reference

12 December 2020

Candidemia: current epidemiologic characteristics and a long-term follow-up of the survivors

1 reference

12 December 2020

Therapeutic efficacy of anidulafungin for the treatment of oesophageal candidiasis, candidemia and invasive candidiasis

1 reference

12 December 2020

A randomized, double-blind trial of anidulafungin versus fluconazole for the treatment of esophageal candidiasis

1 reference

12 December 2020

Acquired resistance to echinocandins in Candida albicans: case report and review

1 reference

12 December 2020

Echinocandins in the management of invasive fungal infections, Part 2

1 reference

12 December 2020

Systemic candidiasis in intensive care units: A multicenter, matched-cohort study

1 reference

12 December 2020

Antifungals in the ICU.

1 reference

12 December 2020

Guidelines for the management of intravascular catheter-related infections

1 reference

12 December 2020

Safety and pharmacokinetics of intravenous anidulafungin in children with neutropenia at high risk for invasive fungal infections

1 reference

12 December 2020

Epidemiology of candidemia in intensive care units

1 reference

12 December 2020

Is Candida really a threat in the ICU?

1 reference

12 December 2020

Candida infections in the intensive care unit: epidemiology, risk factors and therapeutic strategies.

1 reference

12 December 2020

Epidemiology of Candida species infections in critically ill non-immunosuppressed patients

1 reference

12 December 2020

Combination antifungal therapy

1 reference

12 December 2020

Nosocomial bloodstream infections. Secular trends in rates, mortality, and contribution to total hospital deaths

1 reference

12 December 2020

Candida parapsilosis, an emerging fungal pathogen

1 reference

12 December 2020

Rationale for combination antifungal therapy

1 reference

12 December 2020

Anidulafungin--state of affairs from a clinical perspective.

1 reference

12 December 2020

Treatment of invasive fungal infections in immunocompromised and transplant patients: AmBiLoad trial and other new data

1 reference

12 December 2020

Bench-to-bedside review: Candida infections in the intensive care unit

1 reference

12 December 2020

Epidemiology of Candida albicans infections and role of non-Candida-albicans yeasts

1 reference

12 December 2020

Current trends in immunodiagnosis of candidiasis and aspergillosis.

1 reference

12 December 2020

Developments in the epidemiolgy of invasive fungal infections - implications for the empiric and targeted antifungal therapy

1 reference

12 December 2020

The echinocandins: comparison of their pharmacokinetics, pharmacodynamics and clinical applications

1 reference

12 December 2020

Trends in the epidemiology of invasive fungal infections.

1 reference

12 December 2020

Changing epidemiology of systemic fungal infections.

1 reference

12 December 2020

Advances in the diagnosis and treatment of yeast infections: role of the new antifungal agents

1 reference

12 December 2020

The role of Candida in intraperitoneal infections

1 reference

12 December 2020

Guidelines for the Prevention of Intravascular Catheter–Related Infections

1 reference

12 December 2020

Echinocandins in the management of invasive fungal infections, part 1

1 reference

12 December 2020

Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria

1 reference

12 December 2020

[Invasive candidiasis in critically ill patients]

1 reference

12 December 2020

A Comparison of Amphotericin B Alone and Combined with Flucytosine in the Treatment of Cryptoccal Meningitis

1 reference

12 December 2020

Contour-clamped homogeneous electric field gel electrophoresis as a powerful epidemiologic tool in yeast infections

1 reference

12 December 2020

Treatment of invasive candidal infections: systematic review and meta-analysis

1 reference

12 December 2020

Pharmacology and antifungal properties of anidulafungin, a new echinocandin

1 reference

12 December 2020

Anidulafungin: a new echinocandin with a novel profile

1 reference

12 December 2020

Safety and potential of drug interactions of caspofungin and voriconazole in multimorbid patients.

1 reference

12 December 2020

10.2165/11315530-000000000-00000

Identifiers

DOI

1 reference

21 August 2017

1 reference